Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Pathfinder Cell Therapy Inc. Stock Analysis PFND
United States Health Care Nano Cap Pathfinder Cell Therapy, Inc. is a development stage regenerative medicine company. The company is headquartered in Cambridge, Massachusetts. The firm is seeking to develop cell-based and related therapies for the treatment of a range of diseases and medical conditions characterized by organ-specific cell damage. The firm is engaged in developing cell-based therapy for the treatment of diabetes, renal disease, myocardial infarction and other diseases characterized by organ-specific cell damage. The firm has discovered a mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells (PCs) themselves being incorporated into the new tissue. PCs have shown efficacy in approximately three different animal models of diabetes, cardiac ischemia and renal reperfusion injury. The firm has tested these models for PCs from both rat and human sources. As of September 30, 2015, the Company had no revenue generated.
Read More Pathfinder Cell Therapy Inc (PFND) Chart
Financial Metrics & Statements of Pathfinder Cell Therapy Inc (PFND)
FAQ's for Pathfinder Cell Therapy Inc (PFND)
- According to Musaffa’s Shariah screening methodology, Pathfinder Cell Therapy Inc (PFND) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Pathfinder Cell Therapy Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Pathfinder Cell Therapy Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Pathfinder Cell Therapy Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Pathfinder Cell Therapy Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Pathfinder Cell Therapy Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.